La mutation C677T du gène de la 5,10–méthyltétrahydrofolate réductase est associée aux thromboses veineuses idiopathiques

Gilles Berrut(Nantes Université), P Fressinaud(Centre Hospitalier Universitaire d'Angers), I Gallois(Centre Hospitalier Universitaire d'Angers), I. Quéré(Centre Hospitalier Universitaire de Montpellier), Catherine Ternisien(Centre Hospitalier Universitaire d'Angers), Michel Marre(Centre Hospitalier Universitaire d'Angers), Pierre‐Marie Roy(Centre Hospitalier Universitaire d'Angers), A. Ghali(Laboratoires d'Anjou (France))
La Revue de Médecine Interne
September 1, 2003
10.1016/s0248-8663(03)00210-8
Cited by 11

Related Papers

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
|JAMA|2014|739
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
|Human Mutation|2008|429